Impact Partnership Wealth LLC Makes New $226,000 Investment in Amedisys, Inc. (NASDAQ:AMED)

Impact Partnership Wealth LLC bought a new position in Amedisys, Inc. (NASDAQ:AMED) in the fourth quarter, according to its most recent disclosure with the SEC. The firm bought 2,490 shares of the health services provider’s stock, valued at approximately $226,000.

Several other institutional investors have also modified their holdings of AMED. National Bank of Canada FI increased its position in Amedisys by 119.0% during the third quarter. National Bank of Canada FI now owns 55,592 shares of the health services provider’s stock worth $5,365,000 after purchasing an additional 30,213 shares during the last quarter. Dimensional Fund Advisors LP grew its stake in shares of Amedisys by 4.0% in the 2nd quarter. Dimensional Fund Advisors LP now owns 514,166 shares of the health services provider’s stock valued at $47,202,000 after buying an additional 19,660 shares during the period. Geode Capital Management LLC increased its holdings in shares of Amedisys by 1.3% during the 3rd quarter. Geode Capital Management LLC now owns 567,105 shares of the health services provider’s stock worth $54,746,000 after buying an additional 7,071 shares during the last quarter. Quarry LP purchased a new stake in shares of Amedisys during the 3rd quarter valued at approximately $2,569,000. Finally, Charles Schwab Investment Management Inc. lifted its holdings in Amedisys by 2.7% in the third quarter. Charles Schwab Investment Management Inc. now owns 346,082 shares of the health services provider’s stock valued at $33,400,000 after acquiring an additional 9,004 shares during the last quarter. Hedge funds and other institutional investors own 94.36% of the company’s stock.

Amedisys Price Performance

AMED stock opened at $92.80 on Friday. Amedisys, Inc. has a 52-week low of $82.15 and a 52-week high of $98.95. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.05. The stock has a market cap of $3.04 billion, a price-to-earnings ratio of 36.83, a price-to-earnings-growth ratio of 1.83 and a beta of 0.72. The business has a fifty day moving average of $89.17 and a two-hundred day moving average of $94.20.

Amedisys (NASDAQ:AMED) last issued its quarterly earnings data on Wednesday, November 6th. The health services provider reported $1.00 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.19 by ($0.19). Amedisys had a return on equity of 12.20% and a net margin of 3.57%. The business had revenue of $587.67 million for the quarter, compared to analyst estimates of $586.75 million. During the same period in the previous year, the business posted $0.98 earnings per share. The firm’s revenue for the quarter was up 5.7% compared to the same quarter last year. As a group, research analysts anticipate that Amedisys, Inc. will post 4.43 earnings per share for the current year.

Amedisys Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.